ARCH Venture Partners vs Catalio Capital Management, LP
Two firms that co-invest: side by side on stage, sector, check size, and track record, from public filings and the firms' own sites.
| ARCH Venture Partners | Catalio Capital Management, LP | |
|---|---|---|
| Type | Venture capital | Crossover fund |
| HQ | Chicago | New York |
| Founded | 1989 | 2020 |
| Check size | $50K – $250M | — |
| Stages | Seed, Series A, Series B, Series C, Growth | Seed, Series A, Series B, Series C, Growth, Late Stage |
| Sectors | Biotech, Deep Tech, Healthtech | Biotech, Digital Health, Healthtech, Longevity, Medical Devices |
| AUM | $12B | $2.2B |
| Tracked investments | 144 | 106 |
| Exits (acquired/public) | 6 | 2 |
| Led rounds on record | 3 | — |
| Dated deals, last 24 mo | 10 | 3 |
Shared portfolio · 7
eGenesisKardiganNeumora TherapeuticsParabilis MedicinesPheast TherapeuticsResilienceSingular Genomics Systems
Frequently asked questions
- Do ARCH Venture Partners and Catalio Capital Management, LP invest together?
- Yes — ARCH Venture Partners and Catalio Capital Management, LP appear together in 7 tracked portfolio companies, including eGenesis, Kardigan, Neumora Therapeutics, Parabilis Medicines, Pheast Therapeutics.